| 名稱 | β-thalassemia mutation Reference Standard Ⅳ |
| 型號 | CBPD0004 |
| 報價 |  |
| 特點 | β-thalassemia mutation Reference Standard Ⅳ |
產品搜索
相關文章
聯系我們
產品展示 / PRODUCTS
- 詳細內容
| Introduction | |
| Format | Genomic DNA |
| Description | β-thalassemia (β-mediterraneananemia) refers to the A group of hemoglobinopathies in which synthesis is partially or completely inhibited. |
| Technical Data | |
| Variation site | Codon 6(A>T) |
| DNA Change | c.20A>T |
| Zygosity | Heterozygous |
| Allelic Frequency | 50% |
| Transcript | NM_000518.5 |
| Chr position(GRCh37) | Chr11:5248232A>T |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
Figure 1. Codon 6(A>T) Heterozygous |
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
